Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
---|---|---|---|---|
Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
Börsenplätze | Performance | Management | Volatilität | Watchlist |
Historisch | Benchmark | Sharpe Ratio | ||
Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
112.71 USD | USD | % |
---|
Vortag | USD | Datum | 31.01.2025 |
Anzeige
Name | ISIN | Performance | |
---|---|---|---|
21Shares Ripple XRP ETP | CH0454664043 | 335.54% | |
21Shares Stacks Staking ETP | CH1258969042 | 227.84% | |
21Shares Stellar ETP | CH1109575535 | 207.32% | |
21Shares The Sandbox ETP | CH1177361008 | 134.26% | |
21Shares Algorand ETP | CH1146882316 | 125.21% | |
21Shares Sui Staking ETP | CH1360612159 | 40.15% | |
21Shares Immutable ETP | CH1360612142 | -31.53% | |
21Shares Injective Staking ETP | CH1360612134 | -33.73% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Sui Staking ETP | CH1360612159 | 352.99% | |
21Shares Ripple XRP ETP | CH0454664043 | 313.03% | |
21Shares Stellar ETP | CH1109575535 | 211.02% | |
21Shares Aave ETP | CH1135202120 | 157.26% | |
21Shares Stacks Staking ETP | CH1258969042 | 145.10% | |
21Shares Algorand ETP | CH1146882316 | 137.08% | |
21Shares Injective Staking ETP | CH1360612134 | -8.71% | |
21Shares Immutable ETP | CH1360612142 | -30.56% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Ripple XRP ETP | CH0454664043 | 352.88% | |
21Shares Aave ETP | CH1135202120 | 179.54% | |
21Shares Stellar ETP | CH1109575535 | 175.32% | |
21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 161.75% | |
21Shares Bitcoin Core ETP | CH1199067674 | 105.75% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Solana staking ETP | CH1114873776 | 919.13% | |
21Shares Ripple XRP ETP | CH0454664043 | 508.28% | |
21Shares Bitcoin Core ETP | CH1199067674 | 347.20% | |
21Shares Bitcoin ETP | CH0454664001 | 335.92% | |
21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 308.69% |
Fundamentaldaten
Valor | |
ISIN | LU2234857741 |
Emittent | Funds Avenue |
Aufgelegt in | Luxembourg |
Auflagedatum | 30.09.2020 |
Kategorie | Branchen: Gesundheitswesen |
Währung | USD |
Volumen | 50’089’555.91 |
Depotbank | CACEIS Bank, Luxembourg Branch |
Geschäftsjahresende | 31.12. |
Berichtsstand | 06.02.2025 |
Anlagepolitik
So investiert der Ruthenium Fd SA SIF - Global Pharma Fund R USD Acc Fonds: The investment objective of the Sub-Fund is to generate long-term returns consistent with the preservation of capital and prudent investment management. The objective is pursued through a strategy focused on investments in the global healthcare, pharmaceutical and biotechnology sectors or industries. The Sub-Fund will mainly invest in exchange-traded and OTC equity-linked derivatives including but not limited to options, warrants and structured notes. The Sub-Fund may also invest in equities.
ETP Performance: Ruthenium Fd SA SIF - Global Pharma Fund R USD Acc Fonds
Performance 1 Jahr | -2.00 | |
Performance 2 Jahre | -19.91 | |
Performance 3 Jahre | - | |
Performance 5 Jahre | - | |
Performance 10 Jahre | - |